Euoko Group Inc. (OTCBB: EUOK)
Euoko Group Inc. (OTCBB: EUOK) – Tuesday’s shares closed down 4.17% to $2.30. 12,977 shares were traded. Kris Gupta, CFA for Equity Stock Analysis, issued a research report regarding the future potential of Euoko Group. The full report is available at http://www.equitystockanalysis.com. In the report, Kris Gupta writes, �Euoko Group Inc. is engaged in the business of development, marketing and distribution of luxury and mainstream skin treatments. It offers twenty-four luxury skin treatment products categorized into five collections: R-Series for enhancing skin radiance, Y-Series for targeting lines and wrinkles, A-Series for blemish-prone skin, P-Series for diverse environmental protection and W-Series for correcting pigmentation problems.
Euoko Group Inc. owns premium brands that develop, market and distribute scientifically-advanced skin treatments, including the brand, Euoko. Euoko’s current portfolio consists of 24 products spanning five treatment collections that target aging, dull skin tones, skin protection, uneven pigmentation and blemishes. This product line offers comprehensive solutions to such skin concerns as wrinkles, fine lines, under-eye dark circles, dark spots, acne, oxidation, environmental exposure and skin fatigue. Combined with innovative products for basic daily cleansing and facial priming, Euoko offers a complete line of synergistic formulations that target the most demanding luxury consumer. Euoko’s well-appointed, understated primary and secondary packaging communicates innovation, science and modern sophistication, while reflecting the prestige positioning of the portfolio. Euoko sells its product line through premium distribution channels and is represented in more than fifteen countries and territories worldwide. Retail partners of the brand include such premium department stores as Bergdorf Goodman in New York City (USA), Printemps in Paris (France) and La Rinascente in Milan (Italy). Euoko’s products are also sold globally through the company’s internally-operated, multicurrency, multilingual website.
Metro One Development, Inc. (OTCBB: MODI)
Metro One Development, Inc. (OTCBB: MODI) – Tuesday’s shares decreased 35.29% to $0.11. The volume was 74,406. Metro One Development, Inc., a custom builder and property developer in the Greater Toronto Area (’GTA’), Canada, announced today a shareholder update from President and CEO Mr. Stuart Turk.”On behalf of the Metro One Development Management team and Board of Directors, I’m proud to announce that, after a busy month following the sale of our VAR business, we have set the foundation to commence delivering on our business plan as a custom builder and property developer specialist in the GTA. We’ve launched our new website, www.metro-one.com, and will be regularly updating it as our business continues to grow.”
Metro One Development, Inc., previously On The Go Healthcare, Inc., acquires and renovates, to specification, residential (single dwelling and multi-unit), commercial and industrial properties in the Greater Toronto Area (GTA), Ontario, Canada. Whether it’s an existing property or something developed from ‘the ground up’, a smaller home project or a large fully customized and scalable development, the company fabricates the foundations and architecture to create a personalized design solution, tailored to the client’s demands and space intentions. The company also facilitates, and continually invests in, the best available professional and contractual services in the GTA area, as well as obtains and clears all necessary Municipal Residential, Building, Fire and Occupancy permits.
NextGen Bioscience, Inc. (OTC: NXGB)
NextGen Bioscience, Inc. (OTC: NXGB) – Tuesday’s shares fell 20% to $0.08. 565,850 was the volume. NextGen Bioscience, Inc. announced April 10th that Professor William H. Stimson of Scotland is joining its International Scientific Advisory Board. “We are most fortunate to have William H. Stimson join our Scientific Advisory Board,” stated Konstantinos Kardiasmenos, CEO of NextGen. “Professor Stimson, who is considered to be a world leader in cancer research, will be an invaluable asset to NextGen as we continue to develop and license cancer-fighting proteins. He will play a key role in providing scientific advice in the research and development of NextGen’s emerging product portfolio, specifically in the areas of immunological and biochemical processes.”
NextGen Bioscience, Inc. is a drug development biotechnology company focused on the identification, evaluation and acquisition of drug candidates for treatment and prevention of oncological and infectious diseases in human beings. All product candidates target indications with significant unmet need and substantial market potential. Subsequent value-addition at low cost brings benefits to both patients and stakeholders. These programs will then be transferred to larger organizations, either other biotech companies and/or Big Pharma, who have the infrastructure to bring the products to market.
China Voice Holding Corp. (OTC: CHVC)
China Voice Holding Corp. (OTC: CHVC) – Tuesday’s shares closed down 24.32% to $0.56. The volume was 872,756. China Voice Holding Corporation, announced April 15th that it hired James Rapant as Vice President of Business Development for its wholly owned U.S. subsidiary, CVC International, Inc. (CVC). Mr. Rapant will focus on maximizing the profitability of the Company�s new Prepaid Calling Card products and broadening the base of Suppliers for its wholesale termination business. CHVC�s President and CEO Bill Burbank said, �James brings over 16 years of Sales and Business Development experience to the Company. He has vast experience in working with Telecom Carriers and the platforms utilized to support Wholesale Origination and Termination, and Calling Card products. With the Company�s newly expanded network infrastructure and growing U.S. revenues in prepaid calling cards and prepaid cellular products, James is a perfect fit. Since last June, CHVC has been acquiring and establishing many U.S. subsidiaries to support growth in the prepaid calling card and wholesale termination business. Now that we have accomplished our goal of building this business to over $70 Million in annualized revenues, it is time to enter the next phase of our Business Plan to focus on substantially increasing operating margins. The objective will be to establish our Calling Card brand that uses our network and to open new direct international routes for our wholesale termination business while increasing margins.�
China Voice Holding Corp. has a portfolio of next-generation communications products and services doing business in the People’s Republic of China and the U.S. Through its subsidiaries, the Company provides Voice over Internet Protocol (”VoIP”) telephone services, office automation, wireless broadband, unified messaging, video conferencing, mobility services and other advanced voice and data services in China, where the Company has obtained full legal status as a licensed telecommunications company. The Chinese telecommunications market is the largest and fastest growing in the world. CHVC’s focus is on providing innovative telecommunication applications and solutions to customers. CHVC plans to grow its customer base in China and other parts of the world through marketing and sales efforts as well as acquiring and merging with synergistic companies.
